FDA Re-evaluation of Therapeutic Peptides BPC-157 KPV and Semax and the Future of Compounding Regulations
The United States Food and Drug Administration (FDA) has formally signaled a significant shift in its regulatory oversight of several…
Escalating Conflict in the Middle East Pushes Regional Health Systems to Breaking Point as WHO Warns of Compounding Humanitarian Catastrophes
More than ten days into the latest and most severe escalation of hostilities across the Middle East, the structural integrity…
